Want to join the conversation?
$ALXN 2Q15 Call: Commercial organization delivered steady growth in both PNH and aHUS, reflecting the strength of core Soliris business. Advanced Strensiq towards commercialization with first approval in Japan and positive CHMP opinion in Europe. In complement franchise, exceeded target enrollment in registration trial of eculizumab.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!